FDA approves Cassiopea's WINLEVI (CB-03-01, 1% formulation) for Acne
    Technology 8/27/2020

    At a glance
    In this general discussion post, the primary subjects mentioned are
    💧 Nizoral (topical) 1 year
    💊 Dutasteride (oral)
    the tone is 😐 neutral with some growth results.

    Other terms

    The conversation is about the FDA approval of WINLEVI for acne treatment and the anticipation of Breezula, a hair loss treatment using the same active ingredient, which may indicate a positive future for Breezula's release. There is disappointment that Breezula's results are not optimal, but it is seen as progress in hair loss treatment.
    View this post in the Community →

    Similar Community Posts Join

    6 / 105 results

      community Will you try clascosterone when it gets released?

      in Treatment  14 upvotes 3 months ago
      People are interested in trying clascosterone (Breezula) for hair loss, especially those who are too young for finasteride. Some users express concerns about the cost and prescription requirements, while others discuss alternatives like RU58841.

      community Clascoterone - Why are there so few posts if it’s already on the market?

      in Chat  34 upvotes 4 months ago
      Clascoterone is being discussed for hair loss, but its current acne formulation may not be suitable for scalp use due to potential skin irritation and lower dosage compared to Breezula. Users mention other treatments like finasteride, minoxidil, and pyrilutamide, with some expressing skepticism about clascoterone's effectiveness for hair loss.

      community Winlevi coming out in 2019

       13 upvotes 7 years ago
      The conversation discusses the potential release of Winlevi in 2019 by Cassiopeia for hair loss treatment. It suggests a regimen combining minoxidil, Winlevi, Nizoral, and possibly dermarolling, with a comment mentioning Breezula as an alternative to finasteride without side effects.

      community Clascoterone - what we have right now

      in Research/Science  23 upvotes 3 months ago
      Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

    Related Research

    6 / 16 results